DEA Places 6 Synthetic Cannabinoids on Schedule I

December 27, 2023 · MG Magazine

Citing “imminent hazard to public safety,” the Drug Enforcement Administration temporarily placed six synthetic cannabinoids on Schedule I under the Controlled Substances Act, the most restrictive classification reserved for drugs that have no accepted medical use and are subject to abuse. The initial classification period lasts through December 12, 2025, but may be extended or made permanent after further review, the agency said.

According to the DEA, the substances—MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA—mimic the biological effects of delta-9 THC, the main psychoactive ingredient in cannabis. They typically “originate from foreign sources, such as China,” the agency’s notice in the Federal Register states. “Substances in bulk powder form are smuggled via common carrier into the United States and find their way to clandestine designer drug product manufacturing operations located in residential neighborhoods, garages, warehouses, and other similar destinations throughout the country.

“According to online discussion boards and law enforcement encounters, spraying or mixing the [synthetic cannabinoids] with plant material provides a vehicle for the most common route of administration—smoking (using a pipe, a water pipe, or rolling the drug-laced plant material in cigarette papers),” the notice continued.

The powdered substances often take a circuitous route through Europe, New Zealand, or Australia before appearing in the U.S., the DEA noted. Products incorporating the now-banned synthetic cannabinoids are marketed as a “legal high” or “legal alternative to marijuana” and are “readily available” online and in gas stations, convenience stores, and tobacco and head shops, according to the agency. Three of them—MDMB-4en-PINACA, 4F-MDMB-BUTICA, and CUMYL-PEGACLONE—sometimes are mixed with illegal hard drugs including heroin, fentanyl, and methamphetamine.

The American Association of Poison Control Centers (AAPCC) reported the six synthetic cannabinoids can produce “severe, life-threatening health effects, including severe agitation and anxiety, nausea, vomiting, seizures, and hallucinations.” MDMB-4en-PINACA has been responsible for nearly 10,000 poison-control emergencies since 2019, according to AAPCC.

“Emergency department presentations involving MDMB-4en-PINACA or CUMYL-PEGACLONE have included seizures, sudden collapse, involuntary muscle spasms, jerking movements, catatonia, or increased violence,” the DEA’s notice states. “Multiple deaths have been reported involving MDMB-4en-PINACA, 4F-MDMB-BUTICA, and CUMYL-PEGACLONE.” (Full Story)

In category:Federal Policy
Next Post

These Were The Biggest Federal And Congressional Marijuana Policy Developments Of 2023

The year 2023 brought a mixed bag of federal developments in the marijuana space—marked by historic news such as the Biden administration’s rescheduling recommendation and pardon expansion, as well as setbacks on the congressional path to enacting cannabis banking reform.…
Read
Previous Post

Biden Expands Marijuana Pardons With New Proclamation Covering Offenses On Federal Properties

President Joe Biden on Friday issued a proclamation expanding a marijuana pardon initiative he began last year by including for the first time people who committed cannabis possession offenses on federal properties. “Criminal records for marijuana use and possession have…
Read
Random Post

Women of Influence: Dr. Miyabe Shields

Having established quite an interesting online presence as a scientist, educating the public on the endocannabinoid system while also maintaining their identity as a medical cannabis user, Dr. Miyabe Shields is a neurodivergent scientist and a queer person of color.…
Read
Random Post

Pot-Shop Hopping: We Hit a Trio of New Legal Stores in Manhattan, The Bronx and New Jersey

New York and New Jersey are opening new legal adult-use stores at a rapid pace. New Jersey currently has 79 such shops while New York lags behind with 34. New Jersey got a head start in 2022, followed by New…
Read
Random Post

California Assembly Passes Cannabis Cafés Bill

The California Assembly on Wednesday overwhelmingly approved a bill to allow cannabis cafés in the state, KTVU Fox 2 reports. The measure passed the chamber 64-9.   The legislation would permit the sale of non-cannabis products for consumption at the cafés, which is prohibited under current state…
Read
Random Post

Bipartisan Wisconsin Lawmakers File Bill To Create Psilocybin Research Pilot Program For Military Veterans With PTSD

As marijuana reform continues to stagnate in the Wisconsin legislature, bipartisan and bicameral lawmakers have come together to introduce a new bill that would create a psilocybin research pilot program in the state. Sens. Jesse James (R) and Dianne Hesselbein…
Read